Unimicron Technology Corp.

Informe acción TWSE:3037

Capitalización de mercado: NT$244.6b

Unimicron Technology Crecimiento futuro

Future controles de criterios 5/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Unimicron Technology de 62.5% y 19.7% por año respectivamente. Se prevé que el BPA crezca en un 58.4% al año. Se espera que la rentabilidad financiera sea de 20.6% en 3 años.

Información clave

62.5%

Tasa de crecimiento de los beneficios

58.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Electronic24.3%
Tasa de crecimiento de los ingresos19.7%
Rentabilidad financiera futura20.6%
Cobertura de analistas

Good

Última actualización21 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Some Investors May Be Willing To Look Past Unimicron Technology's (TWSE:3037) Soft Earnings

Nov 08
Some Investors May Be Willing To Look Past Unimicron Technology's (TWSE:3037) Soft Earnings

Why Investors Shouldn't Be Surprised By Unimicron Technology Corp.'s (TWSE:3037) 28% Share Price Surge

Nov 07
Why Investors Shouldn't Be Surprised By Unimicron Technology Corp.'s (TWSE:3037) 28% Share Price Surge

Unimicron Technology Corp. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 01
Unimicron Technology Corp. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

At NT$149, Is It Time To Put Unimicron Technology Corp. (TWSE:3037) On Your Watch List?

Sep 29
At NT$149, Is It Time To Put Unimicron Technology Corp. (TWSE:3037) On Your Watch List?

Does Unimicron Technology (TWSE:3037) Have A Healthy Balance Sheet?

Sep 12
Does Unimicron Technology (TWSE:3037) Have A Healthy Balance Sheet?

The Price Is Right For Unimicron Technology Corp. (TWSE:3037) Even After Diving 26%

Aug 17
The Price Is Right For Unimicron Technology Corp. (TWSE:3037) Even After Diving 26%

Analysts Are Updating Their Unimicron Technology Corp. (TWSE:3037) Estimates After Its Second-Quarter Results

Aug 03
Analysts Are Updating Their Unimicron Technology Corp. (TWSE:3037) Estimates After Its Second-Quarter Results

We Like These Underlying Return On Capital Trends At Unimicron Technology (TWSE:3037)

Jul 30
We Like These Underlying Return On Capital Trends At Unimicron Technology (TWSE:3037)

Unimicron Technology's (TWSE:3037) Dividend Is Being Reduced To NT$3

Jun 20
Unimicron Technology's (TWSE:3037) Dividend Is Being Reduced To NT$3

Unimicron Technology Corp.'s (TWSE:3037) Popularity With Investors Is Clear

Jun 12
Unimicron Technology Corp.'s (TWSE:3037) Popularity With Investors Is Clear

Earnings Beat: Unimicron Technology Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Apr 25
Earnings Beat: Unimicron Technology Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Why Unimicron Technology Corp. (TWSE:3037) Could Be Worth Watching

Apr 18
Why Unimicron Technology Corp. (TWSE:3037) Could Be Worth Watching

Unimicron Technology (TWSE:3037) Seems To Use Debt Quite Sensibly

Apr 05
Unimicron Technology (TWSE:3037) Seems To Use Debt Quite Sensibly

Unimicron Technology Corp. (TWSE:3037) Released Earnings Last Week And Analysts Lifted Their Price Target To NT$220

Feb 29
Unimicron Technology Corp. (TWSE:3037) Released Earnings Last Week And Analysts Lifted Their Price Target To NT$220

Unimicron Technology (TPE:3037) Seems To Use Debt Quite Sensibly

Apr 19
Unimicron Technology (TPE:3037) Seems To Use Debt Quite Sensibly

Here's Why We Think Unimicron Technology (TPE:3037) Is Well Worth Watching

Apr 07
Here's Why We Think Unimicron Technology (TPE:3037) Is Well Worth Watching

Unimicron Technology (TPE:3037) Has Rewarded Shareholders With An Exceptional 494% Total Return On Their Investment

Mar 05
Unimicron Technology (TPE:3037) Has Rewarded Shareholders With An Exceptional 494% Total Return On Their Investment

Previsiones de crecimiento de beneficios e ingresos

TWSE:3037 - Estimaciones futuras de los analistas y datos financieros pasados (TWD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/2026170,75829,29228,45747,9649
12/31/2025148,15419,47815,02133,41715
12/31/2024117,7507,358-4,77317,68212
9/30/2024111,6827,933-11,45313,768N/A
6/30/2024106,5159,525-5,65619,501N/A
3/31/2024103,87310,318-4,52819,506N/A
12/31/2023104,03611,9807,96230,900N/A
9/30/2023115,03616,43313,09238,285N/A
6/30/2023125,94422,40627,81253,675N/A
3/31/2023136,34428,04730,12960,828N/A
12/31/2022140,48929,61928,61961,082N/A
9/30/2022134,36427,25540,04771,317N/A
6/30/2022125,05522,90833,99363,774N/A
3/31/2022113,45116,70527,94153,786N/A
12/31/2021104,56313,22219,30242,957N/A
9/30/202196,57510,2755,29226,934N/A
6/30/202191,4697,656-1,30618,265N/A
3/31/202189,1497,2631,35518,321N/A
12/31/202087,8935,4623,36018,164N/A
9/30/202087,8894,493-1,26711,315N/A
6/30/202087,7994,159-29611,840N/A
3/31/202085,8303,2571,07612,600N/A
12/31/201982,5363,260-1,09010,277N/A
9/30/201980,4432,9333,06213,607N/A
6/30/201978,8812,6534,94714,479N/A
3/31/201976,4441,9172,22011,253N/A
12/31/201875,7331,7054,56513,535N/A
9/30/201874,1161,76971711,283N/A
6/30/201869,674465N/A7,365N/A
3/31/201866,893486N/A8,061N/A
12/31/201764,993414N/A5,698N/A
9/30/201762,584325N/A6,306N/A
6/30/201761,502347N/A7,724N/A
3/31/201761,971331N/A8,022N/A
12/31/201662,63812N/A8,925N/A
9/30/201663,771187N/A9,742N/A
6/30/201665,304645N/A10,301N/A
3/31/201666,555627N/A10,031N/A
12/31/201564,650288N/A10,243N/A
9/30/201563,693-881N/A8,177N/A
6/30/201562,778-615N/A7,293N/A
3/31/201561,623-147N/A7,344N/A
12/31/201461,755497N/A6,623N/A
9/30/201459,509579N/A7,028N/A
6/30/201458,754562N/A6,864N/A
3/31/201458,873642N/A7,682N/A
12/31/201359,9351,173N/A9,002N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (62.5% al año) de 3037 es superior a la tasa de ahorro (1.1%).

Beneficios vs. Mercado: Se prevé que los beneficios (62.5% al año) de 3037 crezcan más rápidamente que el mercado TW (19.4% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de 3037 crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (19.7% al año) de 3037 crezcan más rápidamente que los del mercado TW (12.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 19.7% al año) de 3037 crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de 3037 sea alta dentro de 3 años (20.6%)


Descubre empresas en crecimiento